Anemia is common in older adults and associated with adverse health outcomes in epidemiologic studies. A thorough understanding of the complex pathophysiological mechanisms driving anemia in the elderly is lacking; but inflammation, iron restriction, and impaired erythroid maturation are thought to influence the phenotype. We hypothesized that interleukin-6 contributes to this anemia, given its pro-inflammatory activities, its ability to induce hepcidin antimicrobial peptide, and its negative impact on several tissues in older adults. We tested this hypothesis by comparing changes in indices of inflammation, iron metabolism and erythropoiesis in aged C57BL/6 mice to aged mice with targeted deletions of interleukin-6 or hepcidin antimicrobial peptide. Circulating neutrophil and monocyte numbers and inflammatory cytokines increased with age. Declines in hemoglobin concentration and red blood cell number indicated that C57BL/6, interleukin-6 knockout mice, and hepcidin antimicrobial peptide knockout mice all demonstrated impaired erythropoiesis by 24 months. However, the interleukin-6 knock out genotype and the hepcidin antimicrobial peptide knock out genotype resulted in improved erythropoiesis in aged mice. Increased erythropoietic activity in the spleen suggested that the erythroid compartment was stressed in aged C57BL/6 mice compared to aged interleukin-6 knockout mice. Our data suggest C57BL/6 mice are an appropriate mammalian model for the study of anemia with age. Furthermore, although interleukin-6 and hepcidin antimicrobial peptide are not required, they can participate in the development of anemia in aging mice, and could be targeted, pre-clinically, with existing interventions to determine the feasibility of such agents for the treatment of anemia in older adults.
Introduction
Anemia in older adults affects ~10% of community-dwelling adults over age 65 and 20% of those over 85 in developed countries [1] [2] [3] [4] [5] . Ten to 32%
1, 6-8 of anemia cases in adults over 65 years are attributable to inflammation. Other major causes include iron deficiency (12-25% 1, 6-8 and due to gastrointestinal blood loss in many cases); or hematologic malignancy (6-20% [6] [7] [8] ); but 26-44% remain unexplained using current clinical diagnostic criteria 1, [6] [7] [8] [9] . Low hemoglobin has been associated with an increased risk of hospitalization and death 2, 4, 10, 11 , decreased skeletal muscle strength 3 , decreased mobility 12 , and cognitive decline 13, 14 . Aside from effects on the physical well-being of older adults, anemia poses an economic burden to the health care system, as it is associated with significant increases in the cost of treating other conditions in the elderly 15, 16 . Cytokine dysregulation has been observed in healthy older adults 17, 18 . Interleukin-6 (IL-6) is an extensively studied inflammatory cytokine in aging research 19 . It is a mediator of the acute phase response, participating in the recruitment of neutrophils to sites of injury 20 . IL-6 also participates in the switch from acute to chronic inflammation by binding to its soluble receptor and activating the trans-signaling pathway 21 . Circulating levels of IL-6 become elevated in normal aging 22, 23 . Serum IL-6 levels negatively correlate with hemoglobin concentration in chronic disease states 24, 25 , but this relationship also exists in frail older adults without overt inflammatory disease 26 . One possible link between IL-6 and erythropoiesis is stimulation of the iron regulatory hormone, hepcidin antimicrobial peptide (Hepc) by IL-6 27, 28 . Hepc is hypothesized to be a key driver of the anemia in inflammatory states because it sequesters iron 29, 30 , and because it is elevated in the serum of patients with inflammatory conditions and anemia 31 . Hepc may also be elevated independent of IL-6 with age, if it is not effectively cleared by the kidneys 31 ; if it is induced by signals from the transforming growth factor β family 32 ; or if it is induced by other inflammatory cytokines such as IL-1α or β
33
. Thus, IL-6 and Hepc may have independent effects on the development of anemia with age.
The molecular pathogenesis of anemia in older adults is poorly understood and optimal clinical interventions have not been adequately defined. Mouse models may be appropriate tools to investigate the pathophysiology of anemia with age and to test possible interventions in a pre-clinical setting, but the pathogenesis of anemia in aged mice has not been adequately investigated. To analyze the molecular and physiologic mechanisms that may contribute to anemia in aged mice, we compared indices of inflammation, erythropoiesis, and iron metabolism in 2 year old C57BL/6 wild type (WT) mice to 2 month old WT mice. To analyze whether IL-6 participates in the development of anemia of aging, we aged for 24 months mice with targeted deletion of IL-6 (IL-6 KO) along with WT mice and assessed the same features of inflammation, erythropoiesis and iron metabolism. To define whether Hepc contributes to impaired erythropoiesis with age, we followed erythrocyte indices in mice with targeted deletion of Hepc (Hepc KO) and WT mice longitudinally from approximately12 to 24 months. These standard genetic approaches allowed us to assess the requirement of IL-6 or Hepc for features of impaired erythropoiesis in old age. Our results suggest that the anemia which develops in aged C57BL/6 mice is multifactorial. IL-6 and Hepc act as significant and clinically tractable modifiers of the anemia associated with aging in mice, although neither is required for impaired erythropoiesis with age.
Methods
Animal Care: The Johns Hopkins University (JHU) Animal Care and Use Committee or the University of California at Los Angeles (UCLA) Animal Research Committee approved all mouse procedures which conformed to applicable laws and guidelines.
Retired female breeder (RB) C57BL/6 (WT) or B6.129S2-Il6tm1Kopf/J 34 , (stock 2650, IL-6 KO) were purchased from the Jackson Laboratory at 6 to 9 months of age and aged to 24 months in the JHU facility (Table 1) . Virgin female (VF) WT or IL-6 KO mice (Table 2) were born in the JHU colony to breeders purchased from the Jackson Laboratory, then aged to 24 months. Mice with targeted deletion of the Hepcidin 1 gene 35 were backcrossed 10 generations onto the C57BL/6 background (Hepc KO) and aged in the UCLA colony along with their WT controls (Table 3) .
Hematologic and iron parameters:
Complete blood count was determined using the Hemavet 950FS instrument (Drew Scientific, Waterbury, CT) on whole blood samples collected from the facial vein or retro orbital sinus. Non-heme tissue iron was analyzed using bathophenanthroline, a colorimetric reagent, as described 36 . Serum iron was determined using the Ferrozine-based Iron/TIBC Reagent Set (Pointe Scientific Inc, Canton, MI). The manufacturer's protocol was amended to use 1ml of Iron Buffer reagent and 50µl of serum. Serum creatinine was measured by the VetAce ® (Alfa Wasserman Diagnostic Technologies LLC, West Caldwell, NJ, USA).
Enzyme-linked immunosorbent assays:
Frozen serum samples were thawed once, then analyzed for interferon gamma (IFNγ), IL-1β, IL-10, IL-12p70, IL-6, keratinocyte-derived cytokine (KC), and tumor necrosis factor alpha (TNFα) Flow cytometry: Erythroid maturation was determined in bone marrow and spleen as described 37 . We divided Ter119 positive erythroid progenitors into developmental stages I through V 38 using CD44 and forward scatter. Flow Jo software (Tree Star, Ashland,OR, USA) was used to determine frequencies of erythroid progenitors in bone marrow and spleen as well as to determine the median fluorescence intensity of CD71 in individual progenitor populations.
Statistical Analyses: Statistical analyses were performed to study differences between 2-month and 24-month, WT or IL-6 KO, mice using Student's T-test with unequal variances. Genotype by age interactions were assessed using two way factorial ANOVA. Paired T-test was used to assess the longitudinal changes in hematologic parameters of Hepc KO vs. WT mice. For cytokine analyses, the data were log transformed to approximate normality before analysis. Statistical significance was determined as p<0.05.
Further methods are provided in the Online Supplementary Design and Methods.
Results

Aged C57BL/6 mice develop anemia and features of inflammation
To determine whether wild type C57BL/6 (WT) mice developed features of anemia with age, we compared erythrocyte parameters of WT female mice at 2 months of age to those of WT female retired breeder (RB) mice obtained from the Jackson Laboratory at 6-9 months of age and then aged to 24 months in the JHU facility. Here, we define "anemia" as a statistically significant lower hemoglobin concentration than the young control group of the same genotype housed in the same facility. Hemoglobin concentration was significantly lower in 24 month old RB mice than in 2 month old mice. Erythrocyte number was significantly lower in 24 month old RB WT mice compared to 2 month old WT mice (Table 1) .
Beyond changes in erythrocyte parameters, numbers of neutrophils, monocytes and platelets were significantly increased in aged WT mice (Table 1) . Furthermore, the inflammatory cytokines IL-6 and interferon gamma (IFNγ) were significantly increased in aged WT mice (Table 4) . We did not detect significant increases with age in any of the other cytokines tested [IL-1β, IL-10, IL-12p70, keratinocyte-derived cytokine (KC), and tumor necrosis factor alpha (TNFα),]. Increases in these parameters are consistent with an inflammatory phenotype in the aged WT mice. However, the mice were specified pathogen-free and had no obvious tumors or lesions that would indicate overt inflammatory disease. In contrast to increased neutrophils and monocytes, lymphocytes were significantly decreased in 24 month RB WT mice (Table 1 ). This skewing of immune cells, toward the myeloid lineage and away from the lymphoid lineage, is consistent with an aging hematopoietic compartment 39, 40 and the pro-inflammatory state of aging that has been described for older adults 41, 42 .
We were concerned that the RB females may experience anemia or inflammation due to repeated physical stress, tissue injury, remodeling and repair associated with birthing pups. To determine whether virgin female (VF) mice would develop anemia with age like the RB females, we compared erythrocyte parameters of female WT mice at 2 months of age to those of VF WT mice born and aged to 24 months in the JHU facility (Table 2) . Hemoglobin concentration was significantly lower in 24 month old VF mice compared to 2 month old mice (Table 2) . Since VF WT mice that never gave birth to pups also developed anemia with age, we concluded that anemia in aged female C57BL/6 mice is a general finding that is not restricted to the RB WT mice. Like RB WT, 24 month old VF WT mice also developed a phenotype of myeloid skewing. Neutrophils, monocytes, and platelets were all elevated while lymphocytes were significantly decreased in 24 month old VF WT mice (Table 2) .
Targeted deletion of IL-6 modifies anemia in aged retired breeder female mice
Since aged WT mice developed anemia and features of inflammation, we tested the hypothesis that IL-6, a central mediator of chronic inflammation, is required for the development of anemia in aged mice. We compared erythrocyte parameters of female IL-6 KO mice at 2 months of age to 24 month old female RB IL-6 KO mice obtained from the Jackson Laboratory at 6-9 months of age and then aged to 24 months in the JHU facility (Table 1) . Hemoglobin was significantly lower in the aged RB IL-6 KO versus young IL-6 KO mice, but this change was significantly smaller in magnitude than the decline of WT RB mice with age (Table 1, p=0.04 for genotype by age interaction). Additionally, the variability in hemoglobin concentration was smaller in the aged RB IL-6 KO mice than the aged RB WT mice (Table 1) . Though erythrocyte number was lower in aged RB IL-6 KO mice than young, the decline in red blood cell number for aged IL-6 KO RB mice was not as severe as the decline for aged WT RB mice ( We performed similar analyses for VF IL-6 KO mice born and aged to 24 months in our JHU facility ( Table 2) . Like their RB IL-6 KO counterparts, aged VF IL-6 KO mice also had increased neutrophils, monocytes and platelets compared to 2 month controls. Like their RB IL-6 KO counterparts, aged VF IL-6 KO mice were protected from further decline in lymphocyte production (Table 2, p=0.01 for genotype by age interaction). We found hemoglobin was significantly lower in the aged VF IL-6 KO mice than 2 month IL-6 KO mice (Table 2 ). However, there was no difference in the magnitude of the reduction in hemoglobin with age between VF WT mice and VF IL-6 KO mice (Table 2, p=0.61 for genotype by age interaction). This suggested to us that the protective effect of the IL-6 KO genotype on the development of anemia with age in the JHU facility was limited to RB mice.
Targeted deletion of hepcidin modifies anemia in aged mice
Hepc is a central regulator of iron homeostasis and a critical mediator of anemia in some inflammatory states 43 . We tested the hypothesis that Hepc is required for the development of impaired erythropoiesis in aged mice. We followed erythrocyte parameters in peripheral blood of Hepc KO mice longitudinally from 12-13 months to 17-23 months of age in our UCLA facility (Table 3) . Hepc KO mice are severely iron loaded 35 . This excess iron may contribute to the significant increase in erythrocytes and hemoglobin in Hepc KO mice at the 12-13 month baseline when compared to WT mice in the same facility. However, increased erythrocytes and hemoglobin were not observed in 2 month Hepc KO mice in a previous study 44 . Hemoglobin and erythrocyte number declined significantly in mice of both genotypes with age, but the magnitude of the reduction in hemoglobin was significantly less for aging Hepc KO mice than for WT mice ( Table S4 ).
Anemia in aged mice is not iron-restricted
Next, we assessed biochemical features that might account for the anemia in aged WT and IL-6 KO mice (Table 4) . We could not detect statistically significant differences in these parameters between aged VF and aged RB mice (Supplementary Table S5 ). The differences in parameters in Table 4 between young mice and aged VF mice followed the same trend as the differences between young mice and aged RB. In light of these observations, we combined the data for aged RB and aged VF. We found no evidence of frank iron deficiency in aged mice. In fact, liver and spleen non-heme iron stores were significantly increased in aged WT mice and aged IL-6 KO mice as compared to their young genotype controls (Table 4) .
To assess whether iron loading and inflammation affected genes in the Hepc regulatory pathway in aged mice, we investigated the expression of select hepatic genes. We found a non-significant trend toward increased expression of Hepc in the livers of aged WT mice versus young WT mice ( Figure 1 and Supplementary Table S6) . Hepc expression was not low, as would be expected in the context of anemia 31, 45 . We hypothesized Hepc expression in aged, anemic WT mice may be maintained in the same range as young WT mice either in response to inflammatory signals, or in response to iron loading. Liver iron concentration is increased two-fold in aged mice, but we did not observe an increase in Bmp6 expression with age, though it has been demonstrated to respond to iron load. Kautz and colleagues 46 demonstrated less than a two-fold change in Bmp6 in Hepc KO mice which were shown to have a 5-fold increase in liver iron stores, and mainly in hepatocytes 35 . We speculate that the magnitude and pattern of iron loading in aged mice may not be sufficient to significantly induce Bmp6. We further speculate that other pathways, active in aged mice, may interfere with the Bmp6 response to iron loading. We did observe an increase in Id1 expression, which is sensitive to increased iron stores 46 and IL-6
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. IL-6 is the primary mediator of increased Hepc expression in response to inflammation 27 , but we were not able to detect a significant decrease in Hepc in our aged IL-6 KO mice ( Figure 1 and Supplementary Table S6 ).
To test whether aged mice experienced iron-restricted erythropoiesis, we assessed iron availability to the erythron and erythroid iron utilization. Serum iron concentrations were mildly decreased in aged versus young WT mice (Table 4) . Despite this observation, serum iron was not low enough to induce substantial iron-restricted erythropoiesis. MCV and MCH remained close to the normal range in aged WT mice. To determine whether developing erythroblasts were iron-restricted, we assessed median CD71/TfR expression across the stages of erythroblast development ( Figure 2 ). We found no statistically significant increase in median CD71/TfR expression, suggesting iron was not limiting to erythroid precursors.
Impaired erythroid maturation in aged mice
Without strong evidence for iron-restricted erythropoiesis with age, we investigated the development of erythroid progenitor/precursors in aged mice. We could not detect a statistically significant difference in the cellularity of the marrow of aged versus young mice. We did observe a significant reduction in the percentage of committed erythroid progenitor/precursors (Ter119 positive) in the marrow of aged mice (Table 4 and Figure 2A ). Simultaneously, we found an increase in the percentage of granulocytes ( Figure 2A ) which is consistent with increased circulating neutrophils and similar to our previous observations in mice with turpentine-induced sterile abscesses 37 .
We observed that aged mice had greater splenic hematopoiesis; possibly to compensate for the limited erythropoiesis in the bone marrow. We found a significant increase in spleen weight in aged WT mice as well as a significant increase in the percentage of splenic erythroid progenitor/precursors (Table 4 and Supplementary Figure S1 ). A limitation of these results is that we did not assess markers of erythropoiesis in the spleen using gene expression analyses. Extramedullary hematopoiesis in aged WT mice was not sufficient to normalize hemoglobin concentration.
We further investigated whether the development of erythroid progenitors was impaired ( Figure 2 ). We assessed maturation of erythroid progenitor/precursors in the bone marrow with the use of CD44 ( Figure 2B ). We found a slight increase in the percentage of early stage (I-III) progenitors and a slight reduction in the percentage of late stage (V) progenitors in aged WT mice ( Figure 2B , right panel). These results suggest an inhibition of maturation at early stages of development, or destruction of the latest stages of development that we expect contributes to the reduced erythrocyte numbers in the peripheral blood of aged WT mice (Tables 1 and 2 ).
IL-6 KO genotype reduces erythropoietic stress
Compared to aged WT mice, aged IL-6 KO mice appeared to have less erythropoietic stress and more intramedullary erythropoiesis. The percentage of erythroid progenitors and precursors in the bone marrow did not decline in aged IL-6 KO mice to the extent of aged WT mice (Table 4 , p=0.03 for genotype by age interaction). This increased efficiency of marrow erythropoiesis in IL-6 KO mice may have reduced the need for extramedullary erythropoiesis. Spleen weights increased only 50% in aged IL-6 KO mice, compared to a three-fold increase in aged WT mice (Table 4 , p <0.001 for genotype by age interaction). Additionally, aged WT mice produced greater percentages of reticulocytes and splenic erythroid progenitor/precursors than their IL-6 KO counterparts (Table 4) . Aged IL-6 KO mice did not increase splenic iron stores to the same extent as aged WT mice (Table 4 , p <0.001, for genotype by age interaction). We hypothesize this difference may be attributed to depletion by more robust aged IL-6 KO erythroid precursors that utilize iron more efficiently than aged WT erythroid precursors. From these data, we conclude that erythropoiesis is less impaired in aged IL-6 KO mice than aged WT mice.
To determine whether the observed differences in erythropoiesis between aged WT and IL-6 KO mice was attributable to erythropoietin (Epo), the primary survival factor for erythroid progenitors, we assessed serum Epo concentrations. Epo was not detectable in the majority of young and aged mice. However, the range of Epo was greatest for aged WT mice (Table 4) . Epo is primarily produced by the interstitial cells of the kidney and chronic kidney disease can reduce Epo production significantly. We measured serum creatinine as a surrogate of kidney function, but found no difference in serum creatinine with age (Table 4) . Combined, these data suggest greater erythropoiesis in aged IL-6 KO mice is not Epo-dependent.
Discussion
We have demonstrated that C57BL/6 mice are an appropriate mammalian model for the development of anemia with age. We conclude that anemia in aged mice is multifactorial; similar to what has been observed in older adults 1, [6] [7] [8] [9] . Herein, we investigated features of inflammation, iron restriction, and impaired erythroid development to characterize the anemia of aging. We employed two key mouse models with targeted deletions of IL-6 or Hepc to test whether either molecule was required for impaired erythropoiesis with age.
We demonstrated that both VF and RB WT mice model age-associated inflammation in the absence of an overt inflammatory disease. They have increased circulating neutrophils and monocytes and increased concentrations of IL-6 and IFNγ, compared to young controls. All groups of aged RB and VF mice had significantly lower hemoglobin at 24 months of age than their young, genotype controls. Because IL-6 negatively correlates with hemoglobin in various disease states [24] [25] [26] , we tested the hypothesis that IL-6 deficiency could increase hemoglobin at 24 months. 24 month old IL-6 KO RB mice demonstrated anemia, but it was significantly reduced in severity compared to 24 month old WT RB mice. Furthermore, we found aged IL-6 KO mice had less extensive extramedullary erythropoiesis and a greater percentage of committed erythroid progenitors and precursors in the marrow, demonstrating more efficient erythropoiesis.
The pro-anemic effects of the IL-6 pathway were most apparent in RB mice, which experienced greater physiologic stress than their VF counterparts due to pregnancy, tissue injury, and repair that occurs with birthing. Increased physiologic stress in RB WT mice may contribute to the development of more severe anemia than their VF WT counterparts. In contrast to the effect of the IL-6 KO genotype in RB mice, aged VF IL-6 KO mice did not have significantly increased hemoglobin concentration compared to aged VF WT mice. However, VF mice selected for their features of longevity; resistance to tumors, wounds, and other diseases; and housed in a specified pathogen-free environment are not likely to adequately reflect the physiologic stress of the majority of community-dwelling older adults. We conclude that IL-6 reduces the efficiency of erythropoiesis in the bone marrow of aged C57BL/6 mice, resulting in more extensive splenic erythropoiesis that does not fully compensate for the anemia, especially in the context of physiologic stress. Aged WT mice model some features of iron sequestration that may be attributed to inappropriately high Hepc expression. Hepc expression usually declines in the context of anemia 31, 45 , but was not significantly decreased in anemic aged WT mice. Consistent with increased Hepc activity, serum iron concentrations were lower in aged WT mice than in young WT mice despite higher non-heme splenic iron stores. Importantly, the magnitude of the decline in hemoglobin concentration was reduced in aged Hepc KO mice when compared to that of aged WT mice.
Our analysis of mice with targeted deletions in key genes regulating inflammation and iron homeostasis demonstrates that neither IL-6 nor Hepc is required for the anemia that develops with age. The expansion of granulocytes in the marrow and increased neutrophils and monocytes in the peripheral blood of WT and IL-6 KO mice suggest an overall expansion of myeloid cells, yet erythrocyte numbers decline. Lymphocytes also declined in WT mice. This inflammatory phenotype and impaired erythropoiesis that develops in mice is consistent with the changes in the aging hematopoietic compartment described as "myeloid skewing" 48, 49 . We also found that IFNγ, which is known to have deleterious effects on hematopoietic stem cells 50 , was increased with age.
Though aged mice demonstrated the widest distribution of serum Epo concentrations, Epo was not significantly elevated in the majority of aged mice despite anemia. A similar observation of inappropriately low Epo concentrations has been made for older adults with unexplained anemia 6, 7, 9 . These observations may implicate a dysregulated hypoxia response with age that further contributes to anemia of aging.
In summary, we have demonstrated anemia in aged C57BL/6 mice is multifactorial. Though mechanisms independent of Hepc and IL-6 can also impair erythropoiesis with age, future studies should address the use of anemic, aged mice as a pre-clinical model to test the efficacy of interventions targeting Hepc and IL-6 pathways. Additionally, interventions targeting the IFNγ pathway or modifiers of erythroid and myeloid progenitor commitment may be appropriate for pre-clinical testing.
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Supplementary Design and Methods
Animal Care for C57BL/6 and IL-6 KO mice (Johns Hopkins University colony):
Helicobacter hepaticus negative, female mice were housed in ventilated racks (Allentown Caging Equipment) with a 14 hour light cycle at the Johns Hopkins University (JHU) specified pathogen-free barrier facility. Retired female (RB) C57BL/6 (WT) or B6.129S2-Il6tm1Kopf/J 1 , (stock 2650, IL-6 KO) breeders appear in Table 1 and  Table 4 of the main manuscript and Supplementary Tables S1 and S5 . No data were available concerning the number of litters born to the retired female breeders. Virgin female (VF) WT or IL-6 KO mice appear in Table 2 and Table 4 of the main manuscript  and Supplementary Tables S1 and S5 . Food and water were provided ad libitum until 16 hours before sacrifice, at which point the mice were transferred to a clean cage and fasted overnight with only water available ad libitum. Mice were maintained on the 2018SX Teklad Global 18% Protein Extruded Rodent Diet (Harlan Teklad, Madison, WI) which contains 225 parts per million (ppm) iron. Mice with visible or palpable tumors, ulcerative dermatitis, or cachexia were euthanized before 24 months of age and excluded from the analysis.
At necropsy, one VF WT mouse appearing in Tables 2 and 4 of the main manuscript  and Tables S1 and S5 was found to have hydronephrosis and second mouse from the same group was found with an abdominal tumor. Exclusion of these animals did not affect the magnitude or the significance in erythrocyte parameters with age. No IL-6 KO mice appearing in these tables were found with tumors.
For mice appearing in Figure 1 and Table 4 of the main manuscript, RB and VF mice contribute to the values for 24 month old mice, except there were no IL-6 KO VF represented in the qPCR, liver or spleen tissue iron analyses, reticulocyte analysis or Ter+ splenocytes (please see Supplementary Table S5 ). IL-6 KO VF were represented in the spleen weights and Ter+ Marrow in Table 4 .
Animal Care for C57BL/6, IL-6 KO, and Hepc KO mice (University of California Los Angeles colony): WT mice appearing in Table 3 of the main manuscript were born to Jackson Laboratory-derived breeders in the UCLA facility. Hepc KO mice appearing in Table 3 of the main manuscript were born to mice with targeted deletion of the Hepcidin 1 gene 2 which had been backcrossed 10 generations onto the C57BL/6 background.
IL-6 KO mice appearing in Supplementary Table S2 were born to Jackson Laboratoryderived breeders in the UCLA facility. All strains housed in the UCLA facility were maintained on either NIH 31 rodent diet (iron content 336 mg/kg; Harlan Teklad, Indianapolis, Indiana, USA) or Prolab RMH 2000 breeder diet (iron content 440 mg/kg; PMI Nutrition International Inc., Brentwood, Missouri, USA).
At necropsy, 3 of 10 WT mice appearing in Table 3 of the main manuscript and  Supplementary Table S2 were found with tumors at necropsy. Exclusion of these animals did not affect the magnitude or significance of the decline in erythrocyte parameters with age. No IL-6 KO or Hepc KO mice appearing in these tables were found with tumors. Mice that died before 17 months of age were excluded from the analysis.
Blood collection: For longitudinal time points, approximately 100 microliters (mcl) of whole blood was collected for complete blood count from the facial vein using a lancet without anesthesia or from the retro-orbit with isofluorane anesthesia. As a terminal procedure, whole blood was collected from the retro-orbital space of mice anesthetized with intraperitoneal (IP) injection of Avertin (125-240 mg/kg). Only 50 mcl of blood was collected from mice that were analyzed for liver gene expression, to reduce the possibility of transcriptional changes resulting from hypoxia. Due to limitations in blood sample volume, it was not possible to perform every assay on serum samples from every mouse.
Enzyme-linked immunosorbent assays:
Whole blood samples were allowed to clot in serum separator tubes (Becton Dickinson, Franklin Lakes, NJ, USA) approximately 30 minutes. Then serum was collected according to the manufacturer's specifications and immediately frozen at -80ºC. The 7-plex ELISA used to measure the cytokine IL-6 reported values above background for the IL-6 KO mice. We conclude that the ELISA probe may bind to incomplete IL-6 proteins due to the insertion of a stop codon in the middle of the IL-6 gene. PCR-based genotyping analysis confirmed the IL-6 KO genotype of aged RB mice (not shown).
Flow cytometry: Erythroid maturation was determined in bone marrow and spleen samples as described 3 with antibodies to Ter119, CD45, CD71, and/or CD44 (BD Pharmingen, Franklin Lakes, NJ). The cell staining was quantified with the FACS Calibur (Beckton Dickenson). Flow Jo software (Tree Star, Ashland,OR, USA) was used to determine frequencies of erythroid progenitors in bone marrow and spleen as well as to determine the median fluorescence intensity of CD71 (a marker of iron deficiency) in the individual progenitor populations.
Quantitative real-time PCR: Total RNA was isolated from snap frozen mouse livers by the Lowe Family Genomics Core facility using the Trizol reagent method according to the manufacturer's directions (Invitrogen, Carlsbad, CA). The quality of total RNA samples was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Columbia, MD). Reverse transcription was performed by using total RNA isolated from mouse tissues and processed with the Applied Biosystems (Foster City, CA) HighCapacity cDNA Archive kit first-strand synthesis system for RT-PCR according to the manufacturer's protocol. QRT-PCR was performed using the TaqMan assay system from Applied Biosystems. All PCR amplifications were carried out in triplicate on an ABI Prism® 7300 Sequence Detection System, using a fluorogenic 5' nuclease assay (TaqMan® probes). Statistical Analyses: Statistical analyses were performed to study differences between two groups of mice, using Student's T-test with unequal variances. Genotype by age interactions were assessed using two way factorial ANOVA. Paired T-test was used to assess the longitudinal changes in hematologic parameters of Hepc KO vs. WT or IL-6 KO vs. WT mice. For cytokine analyses, the data were log transformed to approximate normality before analysis. Statistical significance was determined as p≤0.05.
Supplementary Results
Retired breeder female mice show evidence of increased inflammation when compared to virgin females.
After their purchase, female RB WT and RB IL-6 KO mice were aged in the JHU facility to 24 months of age as described in the main text. We assessed the complete blood count parameters of female RB WT and RB IL-6 KO mice between 9 and 13 months of age and compared these hematologic features to those of VF mice aged 9 to 13 months in the JHU facility (Table S1 ). Increased circulating neutrophils and platelets in the RB of both WT and IL-6 KO genotype indicated an increase in inflammation with breeding, but breeding status did not significantly impact on hemoglobin concentration at this time point (Table S1 , p= 0.80 for genotype by breeder interaction).
IL-6 KO genotype modifies longitudinal change in hemoglobin in aged mice.
We followed erythrocyte parameters in the peripheral blood of an additional cohort of IL-6 KO mice aged in the UCLA facility longitudinally from 12-14 months to 20-25 months of age (Table S2) . At baseline, IL-6 KO mice had significantly increased erythrocytes and hemoglobin when compared to WT mice. Hemoglobin and erythrocyte number declined significantly in mice of both genotypes with age, but the magnitude of the decline in hemoglobin was significantly less for IL-6 KO mice than for WT mice, sparing hemoglobin in the aged IL-6 KO mice (Table S2 , p=0.016 for genotype by age interaction). The difference in hemoglobin concentration at baseline for 12-14 month old mice in the UCLA facility (Table S2 ) versus the JHU facility (Tables 1 and 2 of the main manuscript) may reflect an earlier decline in hemoglobin in WT animals in the UCLA facility than in the JHU facility. We expect this observation may be related to differences in housing conditions between facilities or to a "survival effect" in the JHU mice which were selected for survival to 24 months of age and had lower incidence of tumors.
Hepc KO genotype modifies longitudinal change in hemoglobin in aged male mice.
We followed erythrocyte parameters in the peripheral blood of male (Table S3) or female (Table S4 ) Hepc KO mice aged in the UCLA facility longitudinally from 12-14 months to 17-23 months of age. At baseline, Hepc KO male and female mice had significantly increased erythrocytes and hemoglobin when compared to WT mice. Hemoglobin concentration declined significantly in mice of both genotypes with age, but the magnitude of the decline in hemoglobin was significantly less for male Hepc KO mice than for male WT mice, sparing hemoglobin in the aged male Hepc KO mice (Table S3 , p=0.006 for genotype by age interaction). We observed the same trend for female Hepc KO mice, but the effect of genotype on the decline in hemoglobin with age did not reach statistical significance.
Effect of breeder status on erythropoietic activity at 24 months
In the main text, we have indicated that erythrocyte number (7.83 ± 1.45 vs. 8.68 ± 0.99, p=0.050) and hemoglobin concentration (10.8 ± 1.8 vs. 12.0 ± 1.2, p=0.023) were significantly lower in 24 month old RB WT compared to 24 month old VF WT mice. We tested whether we could also identify differences in iron stores and erythropoietic activity between RB WT and VF WT mice (Table S5) . We did not detect significant differences for inflammatory cytokines, serum iron and tissue iron concentrations, and measures of erythropoietic activity between these two groups. Thus, the data from aged RB WT and aged VF WT mice were pooled (Table 4 of the primary manuscript). It should be noted however, that due to the small sample size, the insignificant difference between the two groups could reflect insufficient power. Because there was no significant difference in hemoglobin concentration between IL-6 KO aged RB and aged IL-6 KO VF, data for these groups were also pooled. Tissue iron stores, the percentage of committed splenic erythroid progenitors, and reticulocyte numbers were not determined for aged VF IL-6 KO mice as presented in Table S5 .
Analysis of liver gene expression of targets in the Hepcidin regulatory pathway
We have provided Ct values corresponding to samples for each gene assayed in each individual mouse (Table S6) . Relative values are shown in Figure 1A of the main manuscript. All of the Ct values were above background (Ct <36).
Erythroid maturation in bone marrow and spleen
We assessed the erythropoietic activity of the spleen in young and aged WT mice. Figure S1 depicts the gating strategy for erythroid progenitors in the spleen and provides more detail regarding the representation of erythroid precursors throughout stages I through V. We used the same strategy to define erythroid progenitors and precursors in the bone marrow ( Figure 2 of the main text). We found a relatively higher percentage of erythroblasts and reticulocytes (stages II and IV) in the spleens of aged mice. This observation is consistent with the increased spleen weight and the increased percentage of Ter+ splenocytes and suggests extramedullary erythropoiesis is occurring in aged mice.
Supplementary Discussion
Here we have provided further analysis of the differences in hematologic parameters measured in our mouse colonies which were housed in different facilities. These observations may implicate differences in diet, housing, specified pathogens, or the target age of analysis in the development of anemia with age. Because of these extensive, but incompletely understood, differences among various facilities and study designs, we chose to compare either longitudinal or cross-sectional erythrocyte parameters within the same colony and facility.
RB mice are a useful way to accelerate the accomplishment of an aging mouse study. However, we have observed significant differences in erythrocyte parameters of RB mice at 24 months of age when compared to VF mice at 24 months of age despite over a year of housing in the same facility. We found that RB mice have increased circulating neutrophils compared to VF at their baseline bleed between 9 and 13 months in our facility. We hypothesize this may be the result of tissue remodeling after the stress of birthing pups, and while it does not seem to have an immediate impact on hemoglobin concentration, breeding status does seem to negatively impact on hemoglobin concentration by 24 months when the WT RB are compared to WT VF mice. A previous analysis of hematopoiesis in aged C57BL/6 mice compared hematologic features of very old single housed mice to those of very old group housed mice and concluded that stress induced by group housing resulted in changes in hematopoiesis 5 . The stress associated with birthing pups may act in a similar manner, altering hematopoiesis in RB mice.
Despite these differences, we have provided evidence to support the hypothesis that C57BL/6 mice are an appropriate model to study the molecular pathogenesis of the anemia that develops with age. No matter which colony or facility, all aged mice demonstrated a significant decline in hemoglobin from their baseline. Tables   Table S1 . Hematologic features of virgin female and retired breeder mice at 9-13 months of age (JHU facility). Table S2 . Longitudinal analysis of hematologic parameters of IL-6 KO mice with age (UCLA facility).
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